BioSpace News Archive

Preliminary results demonstrate unprecedented levels of primed CD8+ neoantigen-specific cytotoxic T cells and expansion of pre-existing T cells even in low-dose cohorts

TAILORx Study Featured in William L. McGuire Memorial Lecture Award at 2019 San Antonio Breast Cancer Symposium®

Bcureful and the Tuberous Sclerosis Alliance announced plans to formally combine efforts, specifically by establishing the Bcureful Travel Fund at the TS Alliance.

New Modules to Capture Longitudinal Data on Patients with Lung Cancer

Health Care Originals, a leading digital health tech and wearable devices company that provides the only patch-type ambulatory cough monitor in the world, is pleased to announce a collaboration with Dr. Laurie Slovarp, of the University of Montana, who is pioneering a solution for people plagued with chronic cough.

Majority Embrace Pro-Active, Healthy Aging, But Dialogue Not Happening with Health Care Providers

Led by Chief Executive Officer Howard Federoff, M.D., Ph.D., Former Vice Chancellor for Health Affairs and Chief Executive Officer of the University of California Irvine Health System

Health design and innovation studio GoInvo announced that Meghana Karande, MD will join as Medical Director for the firm.

Axonics Modulation Technologies, Inc. announced that the underwriters of its follow-on public offering exercised in full their option to purchase an additional 750,000 shares of common stock from Axonics at the offering price of $22.00 per share, less underwriting discounts and commissions.

Assembly Biosciences, Inc. (Nasdaq: ASMB) (“Assembly”), today announced the pricing of an underwritten public offering of 5,151,515 shares of its common stock to the public at $16.50 per share